UBS Group AG - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 1 filers reported holding UNUM THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,000
-75.0%
340
-96.0%
0.00%
Q1 2020$4,000
-95.4%
8,475
+0.5%
0.00%
Q3 2018$87,000
+81.2%
8,436
+154.1%
0.00%
Q2 2018$48,0003,3200.00%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$14,757,00013.86%
New Leaf Venture Partners, L.L.C. 1,795,545$7,882,0002.16%
SECTORAL ASSET MANAGEMENT INC 1,587,437$6,969,0000.84%
SABBY MANAGEMENT, LLC 206,358$906,0000.44%
COWEN INC. 817,395$3,588,0000.38%
Novo Holdings A/S 473,441$2,078,0000.31%
PLATINUM INVESTMENT MANAGEMENT LTD 260,595$1,144,0000.03%
WASATCH ADVISORS LP 254,449$1,117,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 109,075$479,0000.01%
FIL Ltd 783,423$3,439,0000.01%
View complete list of UNUM THERAPEUTICS INC shareholders